Northern Trust’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-38,679
| Closed | -$784K | – | 4667 |
|
|
2022
Q4 | $784K | Sell |
38,679
-245
| -0.6% | -$4.97K | ﹤0.01% | 3349 |
|
|
2022
Q3 | $418K | Buy |
38,924
+1,498
| +4% | +$16.1K | ﹤0.01% | 3574 |
|
|
2022
Q2 | $449K | Buy |
37,426
+348
| +0.9% | +$4.18K | ﹤0.01% | 3574 |
|
|
2022
Q1 | $794K | Sell |
37,078
-772
| -2% | -$16.5K | ﹤0.01% | 3538 |
|
|
2021
Q4 | $1.27M | Sell |
37,850
-48
| -0.1% | -$1.61K | ﹤0.01% | 3445 |
|
|
2021
Q3 | $976K | Sell |
37,898
-60
| -0.2% | -$1.55K | ﹤0.01% | 3565 |
|
|
2021
Q2 | $507K | Buy |
37,958
+5,668
| +18% | +$75.7K | ﹤0.01% | 3702 |
|
|
2021
Q1 | $343K | Sell |
32,290
-19,344
| -37% | -$205K | ﹤0.01% | 3934 |
|
|
2020
Q4 | $415K | Sell |
51,634
-8,097
| -14% | -$65.1K | ﹤0.01% | 3769 |
|
|
2020
Q3 | $447K | Buy |
59,731
+2,348
| +4% | +$17.6K | ﹤0.01% | 3644 |
|
|
2020
Q2 | $519K | Buy |
57,383
+10,303
| +22% | +$93.2K | ﹤0.01% | 3545 |
|
|
2020
Q1 | $451K | Buy |
47,080
+475
| +1% | +$4.55K | ﹤0.01% | 3484 |
|
|
2019
Q4 | $671K | Buy |
46,605
+3,640
| +8% | +$52.4K | ﹤0.01% | 3501 |
|
|
2019
Q3 | $647K | Hold |
42,965
| – | – | ﹤0.01% | 3496 |
|
|
2019
Q2 | $569K | Hold |
42,965
| – | – | ﹤0.01% | 3525 |
|
|
2019
Q1 | $564K | Buy |
42,965
+1,162
| +3% | +$15.3K | ﹤0.01% | 3512 |
|
|
2018
Q4 | $604K | Buy |
41,803
+1,398
| +3% | +$20.2K | ﹤0.01% | 3512 |
|
|
2018
Q3 | $722K | Buy |
40,405
+16,033
| +66% | +$286K | ﹤0.01% | 3554 |
|
|
2018
Q2 | $350K | Buy |
+24,372
| New | +$350K | ﹤0.01% | 3692 |
|